<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="1" offset="0" totalResults="1"><SearchResults><Trial Id="266108"><Indications><Indication>Pancreas tumor</Indication></Indications><CompaniesCollaborator><Company>Nestle SA</Company></CompaniesCollaborator><CompaniesSponsor><Company>University of Louisville</Company></CompaniesSponsor><Countries><Country>US</Country></Countries><DateChangeLast>2018-10-16T00:00:00Z</DateChangeLast><DateEnd>2019-08-31T00:00:00Z</DateEnd><DateStart>2014-08-31T00:00:00Z</DateStart><Identifiers><Identifier>IMMUNONUTRITION PDAC #14-0779</Identifier><Identifier>NCT02838966</Identifier></Identifiers><InterventionsControlDisplay><Intervention>Nestle Boost high protein drink alone</Intervention></InterventionsControlDisplay><InterventionsPrimaryDisplay><Intervention>Nestle IMPACT Advanced Recovery alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>20</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Recruiting</RecruitmentStatus><Teaser>The purpose of this study is to determine the optimal effective dose for preoperative nutritional supplementation with immunomodulators on immune function and perioperative outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.</Teaser><TrialCategories><Category>Dietary supplement</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Open Label</Term><Term>Active Control</Term><Term>Parallel Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Biomarkers</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Biomarkers - CA19-9 biomarker</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Immune Response</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Inflammatory &amp; Oxidative Stress Markers</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Inflammatory &amp; Oxidative Stress Markers - Assessment of inflammatory/proinflammatory cytokine levels</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Inflammatory &amp; Oxidative Stress Markers - Assessment of lymphocytes</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Laboratory/Diagnostic Measures</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Morbidity Rates</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Nutritional Status</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Performance Status</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Pharmacokinetic/Pharmacodynamic Parameters</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Physical Examination</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Safety and Tolerability</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Safety and Tolerability - Assessment of safety as measured by NCI CTCAE/NCI-CTC criteria</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Safety and Tolerability - Assessment of serious adverse events</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Survival - Assessment of event free survival (EFS)</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of Therapy Related Outcomes - Assessment of Feasibility</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of adverse events</EndpointIndex><EndpointIndex>Pancreas tumor - Assessment of hospitalization - Assessment of duration of hospitalization</EndpointIndex><EndpointIndex>Pancreas tumor - Imaging/Radiological Assessments - Assessment by Magnetic Resonance Imaging (MRI)</EndpointIndex><EndpointIndex>Pancreas tumor - Imaging/Radiological Assessments - Computed tomography (CT)/ PET scans</EndpointIndex><EndpointIndex>Pancreas tumor - Patient Reported Outcomes/Quality of Life Assessments - Assessment of functional status</EndpointIndex><EndpointIndex>Pancreas tumor - Protocol Specified Other Endpoints - Assessment of Other Treatment Related Outcomes</EndpointIndex><EndpointIndex>Pancreas tumor - Protocol Specified Other Endpoints - Assessment of surgical complication</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term></TermsPatientSelection><TitleDisplay>Preoperative Nutrition With Immune Enhancing Nutritional Supplement (Immunomodulation)</TitleDisplay><PatientSegmentTerms><PatientSegment>Pancreas tumor - Subjects with Adenocarcinoma of Pancreas</PatientSegment><PatientSegment>Pancreas tumor - Subjects with Resectable Pancreatic Cancer</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Albumin </BiomarkerName><BiomarkerName> Arginase-1 </BiomarkerName><BiomarkerName> Arginine </BiomarkerName><BiomarkerName> B-lymphocytes </BiomarkerName><BiomarkerName> C-reactive protein </BiomarkerName><BiomarkerName> CA19-9 antigen </BiomarkerName><BiomarkerName> Carcinoembryonic antigen </BiomarkerName><BiomarkerName> Cytotoxic T-Lymphocytes </BiomarkerName><BiomarkerName> Interleukin-6 </BiomarkerName><BiomarkerName> Myeloid-derived suppressor cells </BiomarkerName><BiomarkerName> Natural killer cells </BiomarkerName><BiomarkerName> Serotransferrin </BiomarkerName><BiomarkerName> T-Helper Lymphocytes </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD4 </BiomarkerName><BiomarkerName> T-cell surface glycoprotein CD8 alpha chain </BiomarkerName><BiomarkerName> Total protein </BiomarkerName><BiomarkerName> Transthyretin </BiomarkerName><BiomarkerName> Tumor necrosis factor </BiomarkerName><BiomarkerName> Tumor-Infiltrating Lymphocytes</BiomarkerName></BiomarkerNames><PrimaryCompletionDate type="Anticipated">2019-03-31T00:00:00Z</PrimaryCompletionDate><TrialDuration>60 Months</TrialDuration><NumberOfSites>1</NumberOfSites><ContactNames><Name>Mary Healey</Name><Name>Melissa Schlegel</Name><Name>Melissa Schlegel, CRC</Name><Name>Prejesh Philips, MD</Name></ContactNames></Trial></SearchResults></trialResultsOutput>